Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Vomiting × Dexamethasone × Clear all

Phase

Status

Sponsor Class

OTHER 33 INDUSTRY 10 NETWORK 2 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 3 Recurrence 2 Vomiting 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hypersensitivity 1 Disease Progression 1

Interventions

Tablets 1 Standard of Care 1 Serotonin 5-HT3 Receptor Antagonists 1 Olanzapine 1 Megestrol Acetate 1 Megestrol 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04430361 2020-06-12

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Henan Cancer Hospital

Phase 2 Unknown

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡